25 Years of Proton Pump Inhibitors: A Comprehensive Review

Proton pump inhibitors (PPIs) were clinically introduced more than 25 years ago and have since proven to be invaluable, safe, and effective agents for the management of a variety of acid-related disorders. Although all members in this class act in a similar fashion, inhibiting active parietal cell a...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Gut and liver Ročník 11; číslo 1; s. 27 - 37
Hlavní autoři:	Strand, Daniel S., Kim, Daejin, Peura, David A.
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Korea (South) Editorial Office of Gut and Liver 15.01.2017 Gastroenterology Council for Gut and Liver 거트앤리버 소화기연관학회협의회
Témata:	Anti-Bacterial Agents - therapeutic use Anti-Inflammatory Agents, Non-Steroidal - adverse effects Drug Therapy, Combination Gastroesophageal Reflux - drug therapy Half-Life Helicobacter Infections - drug therapy Humans indications Peptic Ulcer - chemically induced Peptic Ulcer - drug therapy Peptic Ulcer - prevention & control pharmacokinetics proton pump inhibitors Proton Pump Inhibitors - pharmacokinetics Proton Pump Inhibitors - therapeutic use Review risk 내과학 Indications Proton pump inhibitors Risk Review Pharmacokinetics
ISSN:	1976-2283, 2005-1212, 2005-1212
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!